Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
29. Januar 2025 16:15 ET
|
Certara
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth...
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
15. Januar 2025 07:55 ET
|
Certara
Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) --...
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
02. Januar 2025 16:15 ET
|
Certara
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd...
Certara Showcases 2024 Research Wins With Over 100 Papers Published
02. Dezember 2024 16:15 ET
|
Certara
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100...
Certara Reports Third Quarter 2024 Financial Results
06. November 2024 16:15 ET
|
Certara
RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal...
Certara to Participate in the Stephens Annual Investment Conference
28. Oktober 2024 16:15 ET
|
Certara
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
Certara Appoints John Reynders as New Independent Board Member
16. Oktober 2024 16:15 ET
|
Certara
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
09. Oktober 2024 16:15 ET
|
Certara
RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third...
Certara Completes Acquisition of Chemaxon
02. Oktober 2024 16:15 ET
|
Certara
Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.
Certara’s Simcyp Consortium Celebrates 25th Anniversary
24. September 2024 08:00 ET
|
Certara
Certara, a global leader in model-informed drug development, today announced the celebration of the 25th anniversary of the Simcyp® Consortium.